CFO of Tenax Therapeutics Buys Half-Million Options in Bold Bet on Phase 3 Success ?
Insider CFO buys 450k options on Tenax – a bullish signal ahead of Phase‑3 data release that could boost stock after a 52‑week low.
3 minutes to read
Tenax Therapeutics Inc
Tenax Executives Buy Cost‑Zero Options, Betting on Future Pipeline Success【News Flash】
Insider buying fuels short‑term optimism at Tenax Therapeutics, with executives accumulating cost‑free options that signal confidence in the PH‑HFpEF pipeline amid volatility.
4 minutes to read
Tenax Therapeutics CMO Buys Shares, Signals Confidence Ahead of Phase 3 Rollout.
Insider buy by Tenax Therapeutics’ chief medical officer signals confidence as the company heads into Phase‑3 trials for its pulmonary hypertension drug.
3 minutes to read
Tenax Therapeutics Insider Buys 3,000 Options as CEO Signals Optimism Ahead of Phase‑3 Results
Insider buying by Tenax Therapeutics’ owner signals confidence ahead of Phase 3 topline data, suggesting a potential rally amid volatile pricing.
4 minutes to read
Insider Almenoff June Sherie Buys 30,000 Zero‑Price Options on Tenax Therapeutics as Market Scrutinizes Pulmonary Hypertension Pipeline
Insider Almenoff June Sherie’s zero‑price option buy on Tenax hints at confidence in its levosimendan PH‑HFPf pipeline, a potential upside amid market skepticism.
3 minutes to read
Tenax Therapeutics’ CEO Buys Massive Option Block Amid Stock Surge, Betting on Breakthrough Pulmonary Drug.
Insider option buy at Tenax Therapeutics shows executive confidence amid volatility – a bullish signal tied to the company’s clinical pipeline.
4 minutes to read